Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Watching Sesen Bio; Zacks Equity Research Upgrades Stock To Buy

SESEN BIO, INC. (SESN) Upgraded to Buy: What Does It Mean for the Stock? – November 30, 2022 – Zacks.com

byBenzinga Newsdesk

November 30, 2022

1 minute read

SESEN BIO, INC. (SESN) Upgraded to Buy: What Does It Mean for the Stock? – November 30, 2022 – Zacks.com

All The Stocks That Moved Wednesday From CNBC’s ‘Fast Money: Halftime Report’

By AJ Fabino

Today, 10:48 PM

CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

ABB

FDA
News

FDA Accepts Mirati Therapeutics’ New Drug Appliaction For Adagrasib As Treatment Of Previously Treated KRASG12C-Mutated Non-Small Cell Lung Cancer

By Benzinga Newsdesk

Today, 10:48 PM

Mirati Therapeutics, Inc. (NASDAQ:MRTX), a clinical-stage targeted oncology company today announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA)

MRTX

Why Jim Cramer Is Telling Investors To Buy Ford Stock Ahead Of Earnings

By Adam Eckert

Today, 10:48 PM

Investors should buy Ford Motor Company (NYSE: F) ahead of its earnings report, Jim Cramer said Tuesday on CNBC's "Squawk On The Street."

$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today

By Benzinga Insights

Today, 10:48 PM

Bank of America (NYSE:BAC) has outperformed the market over the past 10 years by 1.46% on an annualized…

BAC

Watching Sesen Bio; Zacks Equity Research Upgrades Stock To Buy

Related Posts

All The Stocks That Moved Wednesday From CNBC’s ‘Fast Money: Halftime Report’

FDA Accepts Mirati Therapeutics’ New Drug Appliaction For Adagrasib As Treatment Of Previously Treated KRASG12C-Mutated Non-Small Cell Lung Cancer

Why Jim Cramer Is Telling Investors To Buy Ford Stock Ahead Of Earnings

$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today